ZC3H11A

Zinc finger CCCH domain-containing protein 11A · O75152 · ZC3H11A on Sugi Atlas →

0 patent compounds predicted against ZC3H11A, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to ZC3H11A by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Safety and Dose Escalation Study of Zinc Supplementation in Critically Ill Children PHASE1/PHASE2COMPLETED
Clinical Study of EBV-LMP1 Targeted DNAzyme to Treat Nasopharyngeal Carcinoma PHASE1/PHASE2COMPLETED
A Study of Metastatic Gastrointestinal Cancers Treated With Tumor Infiltrating Lymphocytes in Which the Gene Encoding the Intracellular Immune Checkpoint CISH Is Inhibited Using CRISPR Genetic Engineering PHASE1/PHASE2COMPLETED
PhII 5-Azacytidine Plus Valproic Acid and Eventually Atra in Intermediate II and High Risk MDS PHASE2COMPLETED
Study of the Beach Regimen on Relapsed/Refractory Acute Myeloid Leukemia (R/R AML) PHASE2ACTIVE_NOT_RECRUITING
Efficacy and Safety Assessment of Oral LBH589 in Adult Patients With Advanced Soft TIssue Sarcoma After Pre-treatment Failure PHASE2COMPLETED
A Phase I Study of 5-Azacytidine in Combination With Chemotherapy for Children With Relapsed or Refractory ALL or AML PHASE1COMPLETED
Human Leukocyte Antigen (HLA) - A*2402 Restricted Peptide Vaccine Therapy in Patients With Advanced Esophageal Cancer PHASE1COMPLETED
Zeushield Cytotoxic T Lymphocytes (Z-CTLs) for Relapsed or Refractory Non Small Cell Lung Cancer (NSCLC) EARLY_PHASE1UNKNOWN
Amplification of Zinc Finger Protein 217 Gene in Multiple Myeloma nanUNKNOWN
Characterization of Microbiological and Genetic Features in Prostate Cancer and Their Association with Disease Stage nanENROLLING_BY_INVITATION
Autophagy in Systemic Lupus Erythematosus nanUNKNOWN
PHF19 Gene Expression and EZH2 Gene Deletion in Acute Myeloid Leukemia nanUNKNOWN
Prevalence of a Non-Expressing 11B Mutation in Aka Peoples of the Central African Republic nanCOMPLETED
Zinc and the Synthesis of Zinc Binding Proteins (Protocol B) nanCOMPLETED
Genetics of Endocrine Tumours - Familial Isolated Pituitary Adenoma - FIPA nanRECRUITING
Tecfidera Diffusion Tensor Imaging nanCOMPLETED
Gene Expression in Predicting Response to Paclitaxel in Patients With Breast Cancer nanUNKNOWN
Novel Biomarkers in the Neoplastic Progression of Barrett's Esophagus nanACTIVE_NOT_RECRUITING
Depressed AIRE Gene Expression Causes Immune Cell Dysfunction & Autoimmunity in Down Syndrome nanCOMPLETED
Role of Genetics in Idiopathic Pulmonary Fibrosis (IPF) nanUNKNOWN
PCD New Gene Discovery nanCOMPLETED
Characterization of New Candidate Genes in Cases of Human Inherited Thrombocytopenia (CATCH) nanCOMPLETED
Detection of IKZF1 Deletion Mutation in Patients With Acute Lymphoblastic Leukemia and Its Impact in Therapy nanUNKNOWN
Genetic Characterization of Parkinson's Disease nanCOMPLETED
Whole-genome Sequencing Study in Patients With Diminished Ovarian Reserve nanUNKNOWN
Germline Alterations of Tumor Susceptibility Genes in New York Cancer Patients nanACTIVE_NOT_RECRUITING
Characterization of WAGR Syndrome and Other Chromosome 11 Gene Deletions nanCOMPLETED
Study of Tazemetostat in Adults With Follicular Lymphoma Previously Treated With at Least Two Therapies nanWITHDRAWN
Long Term Prediction of MASH-related HCC Risk by Proteomics nanNOT_YET_RECRUITING

Related proteins — ESM-2 sequence neighbours (a ZC3H11A binder may also engage these)

ProteinNameSimilarity
Q5REG6 1.000 Q5REG6 →
P0DQW0 0.998 P0DQW0 →
Q6NZF1 0.997 Q6NZF1 →
A0A1B0GTU1 0.996 A0A1B0GTU1 →
Q5ZJJ1 0.992 Q5ZJJ1 →
Q8N3X1 0.988 Q8N3X1 →
Q6ZQ03 0.987 Q6ZQ03 →
Q9BTC0 0.987 Q9BTC0 →
Q96T21 0.987 Q96T21 →
Q5F3Z9 0.987 Q5F3Z9 →
Q8BHZ4 0.987 Q8BHZ4 →
Q8BJ05 0.986 Q8BJ05 →
O75410 0.986 O75410 →
Q8C9B9 0.986 Q8C9B9 →
Q4R6F6 0.986 Q4R6F6 →
Q6PJT7 0.986 Q6PJT7 →
Q7TMD5 0.986 Q7TMD5 →
Q61029 0.985 Q61029 →
Q6PGL7 0.985 Q6PGL7 →
Q61464 0.984 Q61464 →
Q80Y19 0.984 Q80Y19 →
A0AVK6 0.984 A0AVK6 →
Q6ZU65 0.984 Q6ZU65 →
Q8BZ32 0.984 Q8BZ32 →
Q3ZC82 0.983 Q3ZC82 →
Q4KLH6 0.983 Q4KLH6 →
Q6ZQ06 0.983 Q6ZQ06 →
B0KYV5 0.983 B0KYV5 →
Q8CG79 0.983 Q8CG79 →
Q99LJ0 0.983 Q99LJ0 →